We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Transcriptome changes during peanut oral immunotherapy and omalizumab treatment.
- Authors
Björkander, Sophia; Merid, Simon Kebede; Brodin, David; Brandström, Josef; Fagerström‐Billai, Fredrik; van der Heiden, Marieke; Konradsen, Jon R.; Kabesch, Michael; van Drunen, Cornelis M.; Golebski, Korneliusz; Maitland‐van der Zee, Anke H.; Potočnik, Uroš; Vijverberg, Susanne J. H.; Nopp, Anna; Nilsson, Caroline; Melén, Erik; Peters, Rachel
- Abstract
We thank all FASTX patients for their participation and the research staff at Forskningscentrum, Södersjukhuset. All participants then underwent an open peanut challenge (pOIT start), before starting peanut OIT (pOIT) in combination with continued omalizumab treatment. The x-axis shows the gene ratio of the overlapping genes of our gene list with the pathway gene set.
- Subjects
PEANUT allergy; OMALIZUMAB; FARNESOID X receptor; PEANUTS; REGULATORY T cells; TRANSCRIPTOMES
- Publication
Pediatric Allergy & Immunology, 2022, Vol 33, Issue 1, p1
- ISSN
0905-6157
- Publication type
Article
- DOI
10.1111/pai.13682